. 2019 Jun 27;8(7):1052–1060. doi: 10.1530/EC-19-0282
This work is licensed under a Table 1.
Demographic, surgical and pathological data of the study population.
| All patients (n = 542) | |
|---|---|
| Sex – female | 300 (55.4) |
| Age (year)a | 53 (43–62) |
| Symptomatic | 272 (50.2) |
| Incidental | 258 (47.6) |
| Non-functional tumor | 435 (80.3) |
| Functional tumor | 107 (19.7) |
| Insulinoma | 103 (18.9) |
| Glucagonoma | 1 (0.2) |
| Somatostatinoma | 1 (0.2) |
| VIPoma | 2 (0.4) |
| Tumor location | |
| Head/neck/uncinate | 256 (47.2) |
| Body/tail | 286 (52.8) |
| Multiple | 23 (4.2) |
| Tumor size (mm)b | 22.0 (14.0–37.3) |
| Synchronous liver metastasis | 19 (3.5) |
| Surgical approach | |
| Open | 273 (50.4) |
| Minimally invasive | 269 (49.6) |
| Type of resection | |
| PPPD or PD | 199 (36.7) |
| Distal pancreatectomy | 249 (45.9) |
| Central pancreatectomy | 32 (5.9) |
| Enucleation | 50 (9.2) |
| Total pancreatectomy | 12 (2.2) |
| Combined operation | |
| Hepatectomy and/or intraoperative RFA | 19 (3.5) |
| Portal vein resection | 16 (3.0) |
| Others | 1 (0.2) |
| Morbidity (Dindo and Clavien’s classification) | |
| Overall | 122 (22.5) |
| Grade I/II | 94 (17.3) |
| Grade III/IV | 27 (5.0) |
| Pancreatic fistula | |
| Grade A | 102 (18.8) |
| Grade B | 34 (6.3) |
| Grade C | 4 (0.7) |
| Postoperative mortality | 1 (0.2) |
| Adjuvant treatment | 27 (5.0) |
| Grade | |
| G1 | 250 (46.1) |
| G2 | 154 (28.4) |
| G3 | 34 (6.3) |
| Unknown | 104 (19.2) |
| AJCC tumor category | |
| T1/T2 | 429 (79.2) |
| T3/T4 | 113 (20.8) |
| N1 status | 67 (12.4) |
| M1 status | 20 (3.7) |
| Lymphovascular invasion | 122 (22.5) |
| Perineueral invasion | 82 (15.1) |
| Resection margin | 31 (5.7) |
Values in parentheses are percentages.
aValues are median (i.q.r.). bValues are median (i.q.r.).
AJCC, American Joint Committee on Cancer; G, tumor grade (World Health Organization classification, 2010); PD, pancreaticoduodenectomy; PPPD, pylorus-preserving pancreaticoduodenectomy; RFA, radiofrequency ablation.